Literature DB >> 22176432

Neurosurgical management of symptomatic thoracic spinal ossification in a patient with fibrodysplasia ossificans progressiva.

Bartosz T Grobelny1, David Rubin, Peter Fleischut, Elayna Rubens, Patricia Fogarty Mack, Matthew Fink, Dimitris G Placantonakis, Eric H Elowitz.   

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by heterotopic ossification of soft connective and muscle tissues, often as the result of minor trauma. The sequelae include joint fusion, accumulation of calcified foci within soft tissues, thoracic insufficiency syndrome, and progressive immobility. The authors report on a patient with FOP who developed severe spinal canal stenosis in the thoracic spine causing substantial myelopathy. He underwent a thoracic laminectomy and resection of a large posterior osteophyte. Unique considerations are required in treating patients with FOP, including steroid administration to prevent ossification and anesthetic technique. The nuances of neurosurgical and medical management as they pertain to this disease are discussed.

Entities:  

Mesh:

Year:  2011        PMID: 22176432     DOI: 10.3171/2011.11.SPINE1164

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  3 in total

1.  Fibrodysplasia Ossificans Progressiva: A Report of Four Cases.

Authors:  Mohamed Elamin; Ashraf Almutasim Ibrahim; Abdalla Omer
Journal:  Cureus       Date:  2022-03-22

2.  General anesthesia for dental procedures in patients with fibrodysplasia ossificans progressiva: a review of 42 cases in 30 patients.

Authors:  Elaine Kilmartin; Zvi Grunwald; Frederick S Kaplan; Burton L Nussbaum
Journal:  Anesth Analg       Date:  2014-02       Impact factor: 5.108

Review 3.  Challenges in the treatment of fibrodysplasia ossificans progressiva.

Authors:  Kardelen Gencer-Atalay; Ekim Can Ozturk; Ilker Yagci; Pinar Ata; Kenan Delil; Zerrin Ozgen; Gulseren Akyuz
Journal:  Rheumatol Int       Date:  2018-10-20       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.